These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30727754)

  • 1. Osteopontin in Vascular Disease.
    Lok ZSY; Lyle AN
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):613-622. PubMed ID: 30727754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.
    Wolak T
    Atherosclerosis; 2014 Oct; 236(2):327-37. PubMed ID: 25128758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.
    Scatena M; Liaw L; Giachelli CM
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2302-9. PubMed ID: 17717292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.
    Cho HJ; Cho HJ; Kim HS
    Curr Atheroscler Rep; 2009 May; 11(3):206-13. PubMed ID: 19361352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival.
    Lee GS; Salazar HF; Joseph G; Lok ZSY; Caroti CM; Weiss D; Taylor WR; Lyle AN
    Lab Invest; 2019 Mar; 99(3):331-345. PubMed ID: 29959420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of osteopontin in cellular signaling and metastatic phenotype.
    El-Tanani MK
    Front Biosci; 2008 May; 13():4276-84. PubMed ID: 18508510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin in Cardiovascular Diseases.
    Shirakawa K; Sano M
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin: a novel inflammatory mediator of cardiovascular disease.
    Singh M; Ananthula S; Milhorn DM; Krishnaswamy G; Singh K
    Front Biosci; 2007 Jan; 12():214-21. PubMed ID: 17127294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin β3 and CD44 levels determine the effects of the OPN-a splicing variant on lung cancer cell growth.
    Sun SJ; Wu CC; Sheu GT; Chang HY; Chen MY; Lin YY; Chuang CY; Hsu SL; Chang JT
    Oncotarget; 2016 Aug; 7(34):55572-55584. PubMed ID: 27487131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.
    Uede T
    Pathol Int; 2011 May; 61(5):265-80. PubMed ID: 21501293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin: role in immune regulation and stress responses.
    Wang KX; Denhardt DT
    Cytokine Growth Factor Rev; 2008; 19(5-6):333-45. PubMed ID: 18952487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.
    Kazanecki CC; Uzwiak DJ; Denhardt DT
    J Cell Biochem; 2007 Nov; 102(4):912-24. PubMed ID: 17910028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and post-translational regulation of osteopontin in cancer.
    Anborgh PH; Mutrie JC; Tuck AB; Chambers AF
    J Cell Commun Signal; 2011 Jun; 5(2):111-22. PubMed ID: 21516514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis.
    Shao JS; Sierra OL; Cohen R; Mecham RP; Kovacs A; Wang J; Distelhorst K; Behrmann A; Halstead LR; Towler DA
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1821-33. PubMed ID: 21597007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin binding to the alpha 4 integrin requires highest affinity integrin conformation, but is independent of post-translational modifications of osteopontin.
    Hui T; Sørensen ES; Rittling SR
    Matrix Biol; 2015 Jan; 41():19-25. PubMed ID: 25446551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.
    Anborgh PH; Mutrie JC; Tuck AB; Chambers AF
    J Cell Mol Med; 2010 Aug; 14(8):2037-44. PubMed ID: 20597997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
    Pedersen TX; Madsen M; Junker N; Christoffersen C; Vikeså J; Bro S; Hultgårdh-Nilsson A; Nielsen LB
    Cardiovasc Res; 2013 Jun; 98(3):352-9. PubMed ID: 23455547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer.
    Ramaiah SK; Rittling S
    Toxicol Sci; 2008 May; 103(1):4-13. PubMed ID: 17890765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multiple functions and mechanisms of osteopontin.
    Icer MA; Gezmen-Karadag M
    Clin Biochem; 2018 Sep; 59():17-24. PubMed ID: 30003880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophages.
    Many GM; Yokosaki Y; Uaesoontrachoon K; Nghiem PP; Bello L; Dadgar S; Yin Y; Damsker JM; Cohen HB; Kornegay JN; Bamman MM; Mosser DM; Nagaraju K; Hoffman EP
    Exp Physiol; 2016 Oct; 101(10):1285-1300. PubMed ID: 27452303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.